18-01-2020 - Results from #15

18-01-2020

52 R. Pirker - Immunotherapy in mLCNEC: is there a role?

52 R. Pirker - Immunotherapy in mLCNEC: is there a role?

53 A. Passaro - Optimal therapeutic algorithm for mLCNEC patients.

53 A. Passaro - Optimal therapeutic algorithm for mLCNEC pat...

54 M. Erman - Molecular targets and therapies for SCLC.

54 M. Erman - Molecular targets and therapies for SCLC.

55 F. Detterbeck - Surgery for SCLC: is there a role?

55 F. Detterbeck - Surgery for SCLC: is there a role?

56 S. Gettinger - Phase I studies with novel immunotherapeutics.

56 S. Gettinger - Phase I studies with novel immunotherapeut...

57 V. Papadimitrakopoulou. - Novel combinations in I-O clinical trials.

57 V. Papadimitrakopoulou. - Novel combinations in I-O clini...

58 F. Barlesi - Optimal dosing and duration of I-O therapy.

58 F. Barlesi - Optimal dosing and duration of I-O therapy.

59 M. Garassino - Sequencing of I-O therapies.

59 M. Garassino - Sequencing of I-O therapies.

60 Discussion

2024 2023 2022 2021 2020 2019 2018 2017 2016

livemed white